SCHEMBL7484378

SCHEMBL7484378

O=Cc1ccccc1N1CCC(CCF)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.37
ADRA1D P25100 5/20 0.37
ADRA1A P35348 5/20 0.37
ADRA1B P35368 5/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PTPN1 P18031 1/20 0.36
PIM1 P11309 2/20 0.35
PIM3 Q86V86 2/20 0.35
PIM2 Q9P1W9 2/20 0.35
DRD2 P14416 1/20 0.35
HTR2A P28223 1/20 0.35
DRD3 P35462 1/20 0.35
USP2 O75604 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663701 0.86 CSF1R (0.45) CHRM4ADRA1DADRA1AADRA1BMEN1
SCHEMBL1663082 0.83 PTPN1 (0.51) ADRA1DADRA1AADRA1BKMT2APTPN1
SCHEMBL23043758 0.79 GAA (0.58) CHRM4MEN1KMT2AUSP2GAA
SCHEMBL2552593 0.79 MAPT (0.41) ADRA1DADRA1AADRA1BMEN1KMT2A
SCHEMBL29954495 0.79 MAPT (0.41) ADRA1DADRA1AADRA1BMEN1KMT2A
SCHEMBL5160655 0.77 MEN1 (0.59) MEN1KMT2ALMNATHRBBLM
SCHEMBL6223691 0.77 KMT2A (0.41) CHRM4MEN1KMT2ALMNATHRB
SCHEMBL3220834 0.76 ALDH1A1 (0.50) MEN1KMT2ALMNATHRBBLM
SCHEMBL23064633 0.76 MEN1 (0.48) MEN1KMT2ALMNATHRBBLM
SCHEMBL31167266 0.74 KEAP1 (0.52) MEN1KMT2ALMNATHRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 WO disclosed